Pancreatic Cancer Research

ResearcherInsermActive in the last 2 years

Paolo Vineis

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8935-4566; OpenAlex author ID A5085715708. Sources: OpenAlex.

Their work

Papers
24 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
62
Papers, trials and grants by year

2011: 2 papers · 2012: 6 papers · 2013: 7 papers · 2014: 1 paper · 2015: 1 paper · 2016: none · 2017: 1 paper · 2018: 1 paper · 2019: 3 papers · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper

Papers 24

  1. Factors influencing the diagnostic basis in pancreatic cancer. A study within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Co-author DOI 10.1016/j.ctarc.2025.101009↗
  2. Plasma concentrations of persistent organic pollutants and pancreatic cancer risk. Last author DOI 10.1093/ije/dyab115↗
  3. Dietary folate intake and pancreatic cancer risk: Results from the European prospective investigation into cancer and nutrition. Co-author DOI 10.1002/ijc.31830↗
  4. CA19-9 and apolipoprotein-A2 isoforms as detection markers for pancreatic cancer: a prospective evaluation. Co-author DOI 10.1002/ijc.31900↗
  5. Methodological issues in a prospective study on plasma concentrations of persistent organic pollutants and pancreatic cancer risk within the EPIC cohort. Co-author DOI 10.1016/j.envres.2018.11.027↗
  6. Circulating plasma phospholipid fatty acids and risk of pancreatic cancer in a large European cohort. Co-author DOI 10.1002/ijc.31797↗
  7. Plasma microRNAs as biomarkers of pancreatic cancer risk in a prospective cohort study. Co-author DOI 10.1002/ijc.30790↗
  8. Plasma carotenoids, vitamin C, retinol and tocopherols levels and pancreatic cancer risk within the European Prospective Investigation into Cancer and Nutritio… Co-author DOI 10.1002/ijc.29175↗
  9. Leukocyte telomere length in relation to pancreatic cancer risk: a prospective study. Co-author DOI 10.1158/1055-9965.epi-14-0247↗
  10. Meat and fish consumption and risk of pancreatic cancer: results from the European Prospective Investigation into Cancer and Nutrition. Co-author DOI 10.1002/ijc.27637↗
  11. Polymorphisms in genes related to one-carbon metabolism are not related to pancreatic cancer in PanScan and PanC4. Co-author DOI 10.1007/s10552-012-0138-0↗
  12. Intake of coffee, decaffeinated coffee, or tea does not affect risk for pancreatic cancer: results from the European Prospective Investigation into Nutrition a… Co-author DOI 10.1016/j.cgh.2013.05.029↗
  13. Dietary intake of acrylamide and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Co-author DOI 10.1093/annonc/mdt255↗
  14. Plasma antibodies to oral bacteria and risk of pancreatic cancer in a large European prospective cohort study. Co-author DOI 10.1136/gutjnl-2012-303006↗
  15. Autoantibodies to Ezrin are an early sign of pancreatic cancer in humans and in genetically engineered mouse models. Co-author DOI 10.1186/1756-8722-6-67↗
  16. An absolute risk model to identify individuals at elevated risk for pancreatic cancer in the general population. Co-author DOI 10.1371/journal.pone.0072311↗
  17. The association of circulating adiponectin levels with pancreatic cancer risk: a study within the prospective EPIC cohort. Co-author DOI 10.1002/ijc.26244↗
  18. Plasma cotinine levels and pancreatic cancer in the EPIC cohort study. Last author DOI 10.1002/ijc.26452↗
  19. Dietary intake of iron, heme-iron and magnesium and pancreatic cancer risk in the European prospective investigation into cancer and nutrition cohort. Co-author DOI 10.1002/ijc.27547↗
  20. Inflammation marker and risk of pancreatic cancer: a nested case-control study within the EPIC cohort. Co-author DOI 10.1038/bjc.2012.172↗
  21. Concentrations of IGF-I and IGFBP-3 and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition. Co-author DOI 10.1038/bjc.2012.19↗
  22. The associations of advanced glycation end products and its soluble receptor with pancreatic cancer risk: a case-control study within the prospective EPIC Coho… Co-author DOI 10.1158/1055-9965.epi-11-1139↗
  23. Diabetes mellitus, glycated haemoglobin and C-peptide levels in relation to pancreatic cancer risk: a study within the European Prospective Investigation into … Co-author DOI 10.1007/s00125-011-2316-0↗
  24. A U-shaped relationship between plasma folate and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition. Last author DOI 10.1016/j.ejca.2011.02.007↗

Closest collaborators

The 25 strongest of 62 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Eric J. Duell · 18 shared papers, 2011–2019 · strength 0.50
  2. H. Bas Bueno-de-Mesquita · 16 shared papers, 2011–2019 · strength 0.47
  3. Verena Andrea Katzke · 8 shared papers, 2013–2025 · strength 0.46
  4. Rudolf Kaaks · 14 shared papers, 2011–2019 · strength 0.38
  5. Malin Sund · 15 shared papers, 2011–2019 · strength 0.35
  6. Weimin Ye · 14 shared papers, 2011–2018 · strength 0.31
  7. María‐Dolores Chirlaque · 4 shared papers, 2012–2025 · strength 0.30
  8. Elio Ríboli · 13 shared papers, 2011–2018 · strength 0.30
  9. Pietro Ferrari · 4 shared papers, 2013–2025 · strength 0.29
  10. Esther Molina‐Montes · 12 shared papers, 2011–2015 · strength 0.25
  11. Miquel S. Porta · 2 shared papers, 2018–2025 · strength 0.23
  12. Vinciane Rebours · 4 shared papers, 2017–2019 · strength 0.21
  13. Guri Skeie · 7 shared papers, 2011–2019 · strength 0.19
  14. Verena A. Grote · 9 shared papers, 2011–2015 · strength 0.18
  15. José A. Pumarega · 1 shared paper, 2025 · strength 0.18
  16. Sandra Milena Colorado-Yohar · 1 shared paper, 2025 · strength 0.18
  17. Marta Crous‐Bou · 1 shared paper, 2025 · strength 0.18
  18. Magda Gasull · 1 shared paper, 2025 · strength 0.18
  19. Dominique S. Michaud · 9 shared papers, 2011–2013 · strength 0.17
  20. Suzanne M. Jeurnink · 8 shared papers, 2011–2015 · strength 0.16
  21. Nadia Slimani · 4 shared papers, 2011–2019 · strength 0.12
  22. Sabine Rohrmann · 6 shared papers, 2011–2013 · strength 0.11
  23. Peter Derk Siersema · 5 shared papers, 2012–2015 · strength 0.11
  24. Federico Canzian · 3 shared papers, 2012–2019 · strength 0.10
  25. Dagfinn Aune · 2 shared papers, 2017–2019 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.